Clinical effect of naturally random allocation to lower systolic blood pressure beginning before the development of hypertension

Hypertension

Volumn 63, Issue 6, 2014, Pages 1182-1188

  Ference, Brian A ^a   Julius, Stevo ^b   Mahajan, Nitin ^a   Levy, Phillip D ^a   Williams, Kim Allan ^a   Flack, John M ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Hypertension; Mendelian randomization analysis; Prevention control

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; EMBASE; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; HYPOTHESIS; ISCHEMIC HEART DISEASE; LONG TERM EXPOSURE; MEDLINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

HYPERTENSION; MENDELIAN RANDOMIZATION ANALYSIS; PREVENTION & CONTROL;

ADOLESCENT; ADULT; AGE FACTORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHILD; CORONARY DISEASE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERTENSION; META-ANALYSIS AS TOPIC; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84902285272     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02734     Document Type: Article

References (21)

1. Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308-315.
2. Carvalho JJ, Baruzzi RG, Howard PF, Poulter N, Alpers MP, Franco LJ, Marcopito LF, Spooner VJ, Dyer AR, Elliott P. Blood pressure in four remote populations in the INTERSALT Study. Hypertension. 1989;14:238-246.
3. Wu M, Ware JH, Feinleib M. On the relation between blood pressure change and initial value. J Chronic Dis. 1980;33:637-644.
4. Ehret GB, Munroe PB, Rice KM, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103-109.
5. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27:1133-1163.
6. Ference BA, Yoo W, Flack JM, Clarke M. A common KIF6 polymorphism increases vulnerability to low-density lipoprotein cholesterol: two meta-analyses and a meta-regression analysis. PLoS One. 2011;6:e28834.
7. Fava C, Sjögren M, Montagnana M, Danese E, Almgren P, Engström G, Nilsson P, Hedblad B, Guidi GC, Minuz P, Melander O. Prediction of blood pressure changes over time and incidence of hypertension by a genetic risk score in Swedes. Hypertension. 2013;61:319-326.
8. Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, Davey Smith G, Sterne JA. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012;21:223-242.
9. Lieb W, Jansen H, Loley C, et al; CARDIoGRAM. Genetic predisposition to higher blood pressure increases coronary artery disease risk. Hypertension. 2013;61:995-1001.
10. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
11. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
12. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677-687.
13. Newton-Cheh C, Johnson T, Gateva V, et al; Wellcome Trust Case Control Consortium. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009;41:666-676.
14. Johnson AD, Newton-Cheh C, Chasman DI, et al; Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium; Global BPgen Consortium; Women's Genome Health Study. Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals. Hypertension. 2011;57:903-910.
15. Johnson T, Gaunt TR, Newhouse SJ, et al; Cardiogenics Consortium; Global BPgen Consortium. Blood pressure loci identified with a gene-centric array. Am J Hum Genet. 2011;89:688-700.
16. Ho JE, Levy D, Rose L, Johnson AD, Ridker PM, Chasman DI. Discovery and replication of novel blood pressure genetic loci in the Women's Genome Health Study. J Hypertens. 2011;29:62-69.
17. Oikonen M, Tikkanen E, Juhola J, et al. Genetic variants and blood pressure in a population-based cohort: the Cardiovascular Risk in Young Finns study. Hypertension. 2011;58:1079-1085.
18. Vasan RS, Massaro JM, Wilson PW, Seshadri S, Wolf PA, Levy D, D'Agostino RB. Antecedent blood pressure and risk of cardiovascular disease: the Framingham Heart Study. Circulation. 2002;105:48-53.
19. Allen N, Berry JD, Ning H, Van Horn L, Dyer A, Lloyd-Jones DM. Impact of blood pressure and blood pressure change during middle age on the remaining lifetime risk for cardiovascular disease: the cardiovascular lifetime risk pooling project. Circulation. 2012;125:37-44.
20. Kostis WJ, Thijs L, Richart T, Kostis JB, Staessen JA. Persistence of mortality reduction after the end of randomized therapy in clinical trials of blood pressure-lowering medications. Hypertension. 2010;56:1060-1068.
21. Nitsch D, Molokhia M, Smeeth L, DeStavola BL, Whittaker JC, Leon DA. Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. Am J Epidemiol. 2006;163:397-403.